Bone Solutions Announces Five New Patents Awarded in FY25, Further Enhancing Its Core Mg OSTEOCRETE Technology
"Bone Solutions is furthering its mission to improve patient outcomes."
These five patents further expand Bone Solutions' industry footprint and allow surgeons and patients to further benefit from the advantages of the Bone Solutions proprietary magnesium-based technology. Mg OSTEOCRETE and Mg OSTEOINJECT (an injectable version of the product) are fast-setting bone substitutes that remodel into bone over time through creeping substitution, meaning they provide needed support to the defect or void during the healing process while transforming into bone at an optimal rate.
'We are pleased to announce the addition of five new patents supplementing our various technologies, ensuring our continued growth and profitability for the company's future,' said Drew Diaz, CEO of Bone Solutions. 'By leveraging our existing technology, Bone Solutions is furthering its mission to improve patient outcomes through our superior magnesium-based orthopedic solutions."
The magnesium component of Mg OSTEOCRETE is the significant differentiator from other bone substitutes on the market. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for ideal osteoconductivity of the product. As a result, Mg OSTEOCRETE and Mg OSTEOINJECT set and cure in situ without migration. The material stimulates cell adhesion, proliferation, and formation of the bone extracellular matrix by osteoblast cells, thus promoting bone growth.
In addition to the superior biological performance of the material, the handling characteristics and formulation are ideal for clinical use. Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it fills. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque.
Mg OSTEOCRETE and Mg OSTEOINJECT are currently being distributed to facilities and surgical centers nationwide for immediate clinical use.
About Bone Solutions Inc.
Bone Solutions Inc. is a specialized medical device company dedicated to improving clinical outcomes through biologically safe, fully resorbable magnesium-based orthopedic implant solutions, with a focus on addressing complex procedures and cost reduction. The company is developing various new orthopedic technologies within its FDA-cleared magnesium-based platform.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
4 minutes ago
- USA Today
NFL reveals reasons why smelling salts are banned in 2025
The 2025 season will introduce some new rules and technology to the NFL, but one change in particular has upset one of the league's best tight ends. The San Francisco 49ers' George Kittle interrupted an interview on NFL Network to voice his displeasure over a new rule banning smelling salts. "I honestly just came up here to air a grievance," Kittle said during an episode of "Inside Training Camp Live" featuring teammate Fred Warner. "Our team got a memo today that smelling salts and ammonia packets were made illegal in the NFL. And I've been distraught all day." Kittle was especially upset because he uses smelling salts often during NFL games. "I'm an every drive guy," Kittle said. "I considered retirement. We got to figure out a middle ground here guys. Somebody help me out, somebody come up with a good idea... I miss those already." Jordan Addison suspension: Vikings WR gets three game ban, NFL announces Training camp scuffle: Baltimore Ravens and Indianapolis Colts get into joint practice brawl That's an under-the-radar change that will impact players across the league. USA TODAY Sports obtained the league memo and here's what the NFL told teams. NFL statement on smelling salts A league official confirmed to USA TODAY Sports that the teams are now prohibited from providing players smelling salts during games. The official declined to be identified because of the sensitivity of the matter. The memo that the NFL sent to teams today read: "In 2024, the FDA issued a warning to companies that produce commercially available ammonia inhalants (AIs), as well as to consumers about the purchase and use of AIs, regarding the lack of evidence supporting the safety or efficacy of AIs marketed for improving mental alertness or boosting energy. The FDA noted potential negative effects from AI use. AIs also have the potential to mask certain neurologic signs and symptoms, including some potential signs of concussion. As a result, the NFL Head, Neck, and Spine Committee recommended prohibiting the use of AIs for any purpose during play in the NFL. In light of this information, effective for the 2025 NFL season, clubs are prohibited from providing or supplying ammonia in any form at NFL games. For clarity, 'ammonia' refers to ammonia capsules, inhalers, ammonia in a cup, and any form of 'smelling salts.' This prohibition applies to all club personnel (including but not limited to team physicians, athletic trainers, strength and conditioning coaches and coaches or other personnel). The prohibition applies through the entirety of all NFL games, including during all pregame activities, and halftime, and applies on the sideline and in stadium locker rooms." NFL players have used smelling salts for years, and it isn't the first sport to ban them. Many boxing organizations banned them years ago because they can mask a severe injury.
Washington Post
5 minutes ago
- Washington Post
How much sugar is in orange juice? Here's what to know.
The Food and Drug Administration on Tuesday proposed a tweak to reduce the amount of sugar required in pasteurized orange juice. But the news from the Trump administration isn't a proposal to lower the amount of sugar in the American diet; it's intended to help Florida's citrus industry because the sugar content of Florida oranges has been steadily dropping due to a bacterial disease afflicting the crop.
Yahoo
6 minutes ago
- Yahoo
Laura Loomer Is Getting a Taste of Her Own Medicine
Laura Loomer's conspiratorial followers are already cannibalizing her for participating in 'the swamp.' Just a day after reports emerged that Defense Secretary Pete Hegseth had tapped the far-right '9/11 truther' to help identify leakers among his staff, Loomer has now herself become the subject of intense scrutiny. Some conspiracists are accusing her of being a 'plant' for pharmaceutical companies concerned about administration policies that could cut into their bottom dollar, reported The Bulwark. The self-appointed 'loyalty enforcer' has had enormous success influencing the Trump administration from the safety of her X account: An analysis by The Daily Beast found that at least 16 individuals were fired from the federal government after Loomer singled them out as covert Democratic agents. But now her intraparty success is coming back to bite her. At issue is the recent firing of Dr. Vinay Prasad, who until last week was in charge of the Food and Drug Administration division that oversees vaccines and gene therapies. Prasad resigned from his position after Loomer accused him of being disloyal to the president, alleging he owned a Trump voodoo doll. (The claim is a mischaracterization of a rhetorical anecdote Prasad spelled out in a podcast episode.) Of note for far-right influencers: Prasad was in the midst of duking it out with Massachusetts-based drug manufacturer Sarepta over the company's drug Elevidys, which treats Duchenne muscular dystrophy. The FDA put Elevidys's clinical trials on hold last month after two patients died while taking the drug, and after another individual passed away while taking a related treatment. All three people died from acute liver toxicity. Shortly before Prasad resigned, the FDA reversed course on its decision, deciding that some patients who still had the ability to walk could receive the drug. Loomer's peers considered the connection between her attacks on Prasad, the new FDA decision, and Prasad's firing fairly obvious. Right-wing Big Pharma critic Kevin Bass accused Loomer of being a 'plant' to 'oust FDA official Vinay Prasad.' American Majority CEO Ned Ryun wrote that Loomer was 'funded by Sarepta Therapeutics to take Vinay out,' referring to the influencer as 'completely nuts.' 'The reason I find this and you so loathsome is that this behavior is the antithesis of the MAGA and MAHA movements,' Ryun added. Loomer has rejected the claims, writing to her 1.7 million followers on X that she hasn't accepted any money from Big Pharma.
